Side-by-side comparison of AI visibility scores, market position, and capabilities
Minneapolis water treatment S&P 500 company (NYSE: PNR) at $4.1B 2024 revenue; Q3 2025 at $1.022B (+3%) with 35% US pool market share and $80M transformation savings competing with Hayward and Fluidra for pool equipment.
Pentair plc is a Minneapolis, Minnesota-based (with UK legal domicile) global water treatment company — publicly traded on the New York Stock Exchange (NYSE: PNR) as an S&P 500 component — operating three business segments: Pool (residential and commercial pool equipment), Water Technologies (residential and commercial water treatment), and Flow (industrial water and fluid management). In fiscal 2024, Pentair generated $4.1 billion in revenue with approximately 9,750 employees serving customers in 150+ countries through 127 key distributors and 84 major retailers. In Q3 2025, Pentair reported $1.022 billion in sales (+3% year-over-year) and adjusted EPS of $1.09 (+14%), with $56 million in year-to-date transformation savings tracking toward $80 million for full-year 2025. Pentair holds approximately 35% market share in the US residential pool equipment market. CEO John Stauch has led the company since 2018. Founded 1966.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.